| 1 |
31586487 | Decrease of spleen invariant natural killer T and natural killer cell numbers in Burkholderia thailandensis-infected C57BL/6 mice. | 2022 Jun |
1 |
| 2 |
34691073 | Activation of iNKT Cells Facilitates Liver Repair After Hepatic Ischemia Reperfusion Injury Through Acceleration of Macrophage Polarization. | 2021 |
1 |
| 3 |
34829848 | Repeated α-GalCer Administration Induces a Type 2 Cytokine-Biased iNKT Cell Response and Exacerbates Atopic Skin Inflammation in Vα14Tg NC/Nga Mice. | 2021 Nov 4 |
2 |
| 4 |
34953481 | Invariant Natural Killer T (iNKT) cells response in human melioidosis. | 2021 Dec 26 |
1 |
| 5 |
33262755 | Serpinb1a Is Dispensable for the Development and Cytokine Response of Invariant Natural Killer T Cell Subsets. | 2020 |
1 |
| 6 |
30766446 | iNKT Cell Activation Exacerbates the Development of Huntington's Disease in R6/2 Transgenic Mice. | 2019 |
2 |
| 7 |
31387637 | Natural killer T cell activation increases iNOS+CD206- M1 macrophage and controls the growth of solid tumor. | 2019 Aug 6 |
2 |
| 8 |
29998597 | Tokishakuyakusan, a traditional Japanese medicine (Kampo) mitigates iNKT cell-mediated pregnancy loss in mice. | 2018 Oct |
1 |
| 9 |
30195979 | Natural killer T cell ligand alpha-galactosylceramide protects against gut ischemia reperfusion-induced organ injury in mice. | 2018 Nov |
1 |
| 10 |
29163480 | Differentiation of IL-17-Producing Invariant Natural Killer T Cells Requires Expression of the Transcription Factor c-Maf. | 2017 |
2 |
| 11 |
26425820 | Interferon-γ constrains cytokine production of group 2 innate lymphoid cells. | 2016 Jan |
2 |
| 12 |
26564814 | CD252 regulates mast cell mediated, CD1d-restricted NKT-cell activation in mice. | 2016 Feb |
1 |
| 13 |
27053764 | TPL2 Kinase Is a Crucial Signaling Factor and Mediator of NKT Effector Cytokine Expression in Immune-Mediated Liver Injury. | 2016 May 15 |
1 |
| 14 |
24616165 | Exposure of polyethylene particles induces interferon-γ expression in a natural killer T lymphocyte and dendritic cell coculture system in vitro: a preliminary study. | 2015 Jan |
1 |
| 15 |
25752588 | α-Galactosylceramide suppresses murine eosinophil production through interferon-γ-dependent induction of NO synthase and CD95. | 2015 Jul |
1 |
| 16 |
26362265 | Tissue-Specific Distribution of iNKT Cells Impacts Their Cytokine Response. | 2015 Sep 15 |
1 |
| 17 |
23182710 | Administration of anti-CD25 mAb leads to impaired α-galactosylceramide-mediated induction of IFN-γ production in a murine model. | 2013 Jun |
2 |
| 18 |
23467936 | Exosome-like nanoparticles from intestinal mucosal cells carry prostaglandin E2 and suppress activation of liver NKT cells. | 2013 Apr 1 |
1 |
| 19 |
23686838 | Invariant NKT cell activation induces neutrophil accumulation and hepatitis: opposite regulation by IL-4 and IFN-γ. | 2013 Oct |
2 |
| 20 |
23860186 | The nanoparticulation by octaarginine-modified liposome improves α-galactosylceramide-mediated antitumor therapy via systemic administration. | 2013 Oct 28 |
1 |
| 21 |
23994875 | Toll-like receptor agonists and alpha-galactosylceramide synergistically enhance the production of interferon-gamma in murine splenocytes. | 2013 |
1 |
| 22 |
23994885 | Antitumor impact of interferon-γ producing CD1d-restricted NKT cells in murine malignant mesothelioma. | 2013 Oct |
1 |
| 23 |
24158093 | An intact immune system is required for the anticancer activities of histone deacetylase inhibitors. | 2013 Dec 15 |
2 |
| 24 |
21113080 | Low susceptibility of NC/Nga mice to the lipopolysaccharide-mediated lethality with D-galactosamine sensitization and the involvement of fewer natural killer T cells. | 2012 Feb |
2 |
| 25 |
21803777 | A new experimental murine model for lipopolysaccharide-mediated lethal shock with lung injury. | 2012 Apr |
2 |
| 26 |
23121668 | Activated natural killer T cells producing interferon-gamma elicit promoting activity to murine dendritic cell-based autoimmune hepatic inflammation. | 2012 Dec |
1 |
| 27 |
25436681 | Toward realization of the promise of regenerative medicine. | 2012 Jun |
2 |
| 28 |
21391989 | Activation of natural killer T cells by α-carba-GalCer (RCAI-56), a novel synthetic glycolipid ligand, suppresses murine collagen-induced arthritis. | 2011 May |
2 |
| 29 |
21564001 | Targeting the diverse immunological functions expressed by hepatic NKT cells. | 2011 Aug |
2 |
| 30 |
21603172 | Invariant NKT Cell Lines Derived from the NOD·H2 Mouse Enhance Autoimmune Thyroiditis. | 2011 |
1 |
| 31 |
22041707 | [Activation of natural killer T cells by NK-4, a criptocyanine dye]. | 2011 |
2 |
| 32 |
20038794 | IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. | 2010 Jan |
4 |
| 33 |
20039304 | The A2aR adenosine receptor controls cytokine production in iNKT cells. | 2010 Mar |
1 |
| 34 |
20410490 | Secretion of IFN-gamma but not IL-17 by CD1d-restricted NKT cells enhances rejection of skin grafts expressing epithelial cell-derived antigen. | 2010 May 15 |
1 |
| 35 |
20593019 | Defective NKT cell activation by CD1d+ TRAMP prostate tumor cells is corrected by interleukin-12 with α-galactosylceramide. | 2010 Jun 25 |
1 |
| 36 |
20659123 | Endotoxin-induced lung injury in α-galactosylceramide-sensitized mice is caused by failure of interleukin-4 production in lung natural killer T cells. | 2010 Oct |
2 |
| 37 |
19010461 | Murine NKT cells produce Th17 cytokine interleukin-22. | 2009 |
1 |
| 38 |
19564135 | Beta-galactosylceramide alters invariant natural killer T cell function and is effective treatment for lupus. | 2009 Sep |
1 |
| 39 |
19584680 | Prevention of early loss of transplanted islets in the liver of mice by adenosine. | 2009 Jul 15 |
1 |
| 40 |
19915050 | SOCS3 in T and NKT cells negatively regulates cytokine production and ameliorates ConA-induced hepatitis. | 2009 Dec 1 |
1 |
| 41 |
17693934 | Prevention of injury-induced suppression of T-cell immunity by the CD1d/NKT cell-specific ligand alpha-galactosylceramide. | 2008 Feb |
1 |
| 42 |
17998313 | c-Jun NH2-terminal kinase 2 inhibits gamma interferon production during Anaplasma phagocytophilum infection. | 2008 Jan |
2 |
| 43 |
18098320 | Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis. | 2008 Feb |
1 |
| 44 |
18194275 | H2-D(d)-mediated upregulation of interleukin-4 production by natural killer T-cell and dendritic cell interaction. | 2008 May |
2 |
| 45 |
18354175 | Aberrant genetic control of invariant TCR-bearing NKT cell function in New Zealand mouse strains: possible involvement in systemic lupus erythematosus pathogenesis. | 2008 Apr 1 |
1 |
| 46 |
18458153 | Prophylaxis of lipopolysaccharide-induced shock by alpha-galactosylceramide. | 2008 Aug |
1 |
| 47 |
17046969 | Pivotal advance: alpha-galactosylceramide induces protection against lipopolysaccharide-induced shock. | 2007 Mar |
1 |
| 48 |
17259803 | Role of alpha-galactosylceramide-activated Valpha14 natural killer T cells in the regulation of allergic diseases. | 2007 Mar |
2 |
| 49 |
17314060 | Role of interferon-gamma in Valpha14+ natural killer T cell-mediated host defense against Streptococcus pneumoniae infection in murine lungs. | 2007 Mar |
2 |
| 50 |
17330820 | IL-18 time-dependently modulates Th1/Th2 cytokine production by ligand-activated NKT cells. | 2007 Apr |
1 |